The new coding model released Thursday afternoon, entitled GPT-5.3-Codex, builds on OpenAI’s GPT-5.2-Codex model and combines insights from the AI company’s GPT-5.2 model, which excels on non-coding ...
Kith is kicking off its 15th anniversary in 2026 by joining forces with longtime collaborator Asics for a new Gel-Kayano 12.1 collection dropping soon. The trio of Kith x Asics Gel-Kayano 12.1 ...
Washington State Standard is part of States Newsroom, a network of news bureaus supported by grants and a coalition of donors as a 501(c)(3) public charity. Daimler's Freightliner Cascadia big rig.
Washington is close to opening a new incentive program for commercial fleet operators to transition trucks and other vehicles to models that run on electric or hydrogen power. Industry groups and ...
This is the first story in a two-part series recapping Colorado’s second year of wolf reintroduction. Colorado’s wolf program was eventful from the start in 2025. Just over a week into the new year, ...
COLUMBUS, Ohio (WCMH) — For months, NBC4 Investigates has been digging into concerns from Central Ohio families who say the dream of homeownership has turned into years of uncertainty. They’re part of ...
[1] Plans to develop Albuquerque westside apartment complex move forward – An area in Albuquerque’s west side has been the subject of debate as community and tribal members have argued against the ...
PITTSBURGH — Highmark awarded a $1 million grant to South Side-based Achieva to build a home transition program for children with complex medical needs. The grant will bolster the Beyond Boundaries ...
OSHKOSH (WLUK) -- UW-Oshkosh is turning the former Center for Equity and Diversity, which it unsuccessfully tried to sell, into new offices for the school's football program. About a year ago, the ...
TOWER BARRACKS, Germany – With roads and utilities now in place, buildings are the next step for the new Operational Readiness Training Complex being built in Grafenwoehr, Germany. Leaders from the ...
Neridronate granted FDA Breakthrough Therapy, Fast-Track, and Orphan Drug designations; pivotal Phase 3 trial planned to start in the first quarter of 2026 Jay Hagan joins as Chief Executive Officer ...